 |
| |
| |
 |
|
 |
| Peptron Signs Licensing Agreement with Daewoong Pharmaceutical Co. Ltd. on the Development of 1 month Injectable Formulation of Octreotide Acetate, an Acromegaly Treatment Drug |
|
 |
| Selected as "Advanced Technology Center, ATC" in the field of Automatic Peptide Synthesizer Development, Ministry of Commerce, Industry, and Energy |
|
 |
| Peptron Signs Exclusive Contract Peptide Synthesis Agreements with Chemicon International and BD Bioscience |
|
 |
| Peptron Signs Contract Peptide Synthesis Agreements with Merck Research Laboratories |
|
 |
| 1 Month Injectable Formulation of Leuprolide Acetate, a Prostate Cancer Treatment Agent was Approved by the Korean FDA |
|
| |
 |
|
|
| Peptron Exports Custom Peptides to Over 25 Nations Worldwide |
|
 |
| Third Generation Automatic Peptide Synthesizer , PeptrEX™, was Developed |
|
|
| Peptron Signs Licensing Agreement with Daewoong Pharmaceutical Co. Ltd. on the Development of 1-3 Month Injectable Formulation of Leuprolide Acetate |
|
| |
 |
|
 |
Second Generation Automatic Peptide Synthesizer,  was Developed |
|
| |
 |
|
 |
| ISO 9001 Certified for the Custom Peptide Synthesis Process |
|
|
| Selected as "INNO-BIZ" Company, Ministry of Science & Technology |
|
|
| First Generation Automatic Peptide Synthesizer, Xylophone, was Developed |
|
| |
 |
|
|
| Selected as "Innovative Small & Medium Business Company" by Small & Medium Business Administration |
|
| |
 |
|
 |
| Selected as "Venture Company" by the Korean Government |
|
 |
| First Custom Peptide Exported to Japan |
|
| |
 |
|
|
| First Custom Peptide Synthesized |
|
|
| Peptron Biochemistry Research Institute Established |
|
| |
 |
|
|
| Peptron, Inc. Founded |
|
| |
